⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Mithrl and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Mithrl
↗San Francisco, USA
Mithrl is an AI-native health-tech company that provides a 'Scientific Decision Engine' designed to automate complex R&D workflows for enterprise life sciences teams. By utilizing agentic AI and natural language interfaces, the platform helps scientists move from raw data (such as NGS and omics datasets) to defensible, auditable insights in days rather than months, effectively eliminating dry-lab bottlenecks.
The company focuses on enabling infrastructure for scientific decision-making, supporting tasks such as biomarker discovery, drug target identification, and mechanism of action decoding. Mithrl serves a customer base of biotech and pharmaceutical companies, aiming to accelerate the path from research idea to IND (Investigational New Drug) application.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Digital Health / AI for R&D
SIZE & FINANCIALS
Employees:1-50
Founded:2023
Ownership:private
Status:operating
FUNDING
Stage:Seed
Total Raised:$4M
Investors:Bonfire Ventures
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Enabling Technology)
Modalities:Genomics, Transcriptomics, Proteomics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Elephas Biosciences (Collaboration on real-time tumor profiling and immunotherapy response insights)
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Vivek Adarsh - Co-Founder & CEO
Shara Balakrishnan - Co-Founder & CTO
Sarosh Naseem - VP, Sales
Scientific Founders:Vivek Adarsh, Shara Balakrishnan
LINKS
Website:mithrl.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Mithrl. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.